"Safety and efficacy analyses across age and body mass index subgroups in East Asian participants with type 2 diabetes in the phase 3 tirzepatide studies (SURPASS programme)"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Safety and efficacy analyses across age and body mass index subgroups in East Asian participants with type 2 diabetes in the phase 3 tirzepatide studies (SURPASS programme)

To assess the safety and efficacy of tirzepatide in people of East Asian descent based on age and body mass index (BMI). Click to show full abstract

To assess the safety and efficacy of tirzepatide in people of East Asian descent based on age and body mass index (BMI).

Keywords: east asian; age body; safety efficacy; body mass; mass index

Journal Title: Diabetes
Year Published: 2022

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended